Biopharmaceutical company OnKure announced the appointment of Rogan Nunn as general counsel and secretary.

Nunn will report to Nicholas Saccomano, president and chief executive.

Prior to this, he served as general counsel, America at ADC Therapeutics. Before that, he served as EVP, general counsel, and secretary of Array Biopharma. Earlier, he was a corporate and M&A specialist at Skadden, Arps, Slate, Meagher & Flom.